Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1921 AL 1935

Current evidence on the effect of dietary polyphenols intake on chronic diseases

Costa C, Tsatsakis A, Mamoulakis C, Teodoro M, Briguglio G, Caruso E, Tsoukalas D, Margina D, Dardiotis E, Kouretas D, Fenga C.

Food Chem Toxicol. 2017 Dec;110:286-299. doi: 10.1016/j.fct.2017.10.023. Epub 2017 Oct 14.

Association between Parkinson's disease and risk of prostate cancer in different populations: An updated meta-analysis

Chen C, Zheng H, Hu Z.

Sci Rep. 2017 Oct 18;7(1):13449. doi: 10.1038/s41598-017-13834-x.

Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications

Gao F, Yang J, Wang D, Li C, Fu Y, Wang H, He W, Zhang J.

Front Neurol. 2017 Oct 4;8:527. doi: 10.3389/fneur.2017.00527. eCollection 2017.

[Ophthalmic disorders as a manifestation of Parkinson's disease]

Chesnokova NB, Pavlenko TA, Ugrumov MV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(9):124-131. doi: 10.17116/jnevro201711791124-131.

Neuroprotective Surgical Strategies in Parkinson's Disease: Role of Preclinical Data

Torres N, Molet J, Moro C, Mitrofanis J, Benabid AL.

Int J Mol Sci. 2017 Oct 20;18(10):2190. doi: 10.3390/ijms18102190.

Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease

Chitramuthu BP, Bennett HPJ, Bateman A.

Brain. 2017 Dec 1;140(12):3081-3104. doi: 10.1093/brain/awx198.

How Wearable Sensors Can Support Parkinson's Disease Diagnosis and Treatment: A Systematic Review

Rovini E, Maremmani C, Cavallo F.

Front Neurosci. 2017 Oct 6;11:555. doi: 10.3389/fnins.2017.00555. eCollection 2017.

Apraxia: Review and Update

Park JE.

J Clin Neurol. 2017 Oct;13(4):317-324. doi: 10.3988/jcn.2017.13.4.317.

Development of Parkinsonism symptoms immediately after severe head injury

Abu Talh K, Sulaiman M, Joshi D, Hamed S.

Neurosciences (Riyadh). 2017 Oct;22(4):308-310. doi: 10.17712/nsj.2017.4.20170240.

Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience

Balash Y, Bar-Lev Schleider L, Korczyn AD, Shabtai H, Knaani J, Rosenberg A, Baruch Y, Djaldetti R, Giladi N, Gurevich T.

Clin Neuropharmacol. 2017 Nov/Dec;40(6):268-272. doi: 10.1097/WNF.0000000000000246.

A Phase Ib Randomized Controlled Study to Evaluate the Effectiveness of a Single-Dose of the NR2B Selective N-Methyl-D-Aspartate Antagonist MK-0657 on Levodopa-Induced Dyskinesias and Motor Symptoms in Patients With Parkinson Disease

Herring WJ, Assaid C, Budd K, Vargo R, Mazenko RS, Lines C, Ellenbogen A, Verhagen Metman L.

Clin Neuropharmacol. 2017 Nov/Dec;40(6):255-260. doi: 10.1097/WNF.0000000000000241.

Possible Biological and Clinical Applications of Phenothiazines

Varga B, Csonka Á, Csonka A, Molnár J, Amaral L, Spengler G.

Anticancer Res. 2017 Nov;37(11):5983-5993. doi: 10.21873/anticanres.12045.

[Subthalamic nucleus: from circuits, functions to a deep brain stimulation target for the treatment of Parkinson's disease]

Li GY, Zhuang QX, Li B, Wang JJ, Zhu JN.

Sheng Li Xue Bao. 2017 Oct 25;69(5):611-622.

[Gait disturbances and falls in various types of dementias]

Knast K, Gorzkowska A, Bieniek I, Rudzińska-Bar M.

Wiad Lek. 2017;70(4):784-789.

Biomarkers and Stimulation Algorithms for Adaptive Brain Stimulation

Hoang KB, Cassar IR, Grill WM, Turner DA.

Front Neurosci. 2017 Oct 10;11:564. doi: 10.3389/fnins.2017.00564. eCollection 2017.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias